MFHAS1 and Parkinson disease: For example, LRRK2 is the focus of many investigations within PD research,38 whereas MASL1 is relatively understudied.21 Interestingly, this trend differs when considering the interactomes prior to applying the confidence threshold (i.e., when retaining all reported interactors regardless of replication; Figure 2B).